Clinical Trial

Impact of Tyrosine Kinase Inhibitors on Glucose Level and Lipid Metabolism in Chronic Myeloid Leukemia Patients

Name: Impact of Tyrosine Kinase Inhibitors on Glucose Level and Lipid Metabolism in Chronic Myeloid Leukemia Patients — clinical trial record (NCT07413263)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

to known the impact of drugs that used in CML pt as TKIs on glucose and lipid metabolism

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-02-09.

Trial Details

NCT Number	NCT07413263
Lead Sponsor	Assiut University
Conditions	Chronic Myeloid Leukemia
Enrollment	75 participants
Start Date	2026-05-01
Primary Completion	2027-12-30 (estimated)
Study Completion	2028-12-30 (estimated)
Updated on ClinicalTrials.gov	2026-02-18